Sign in

CIK 0001674632 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Beta Bionics, Inc.

Sign in to watch
Ticker
BBNX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475386878
Phone
949-427-7785
Business address
11 HUGHES, IRVINE, CA, 92618
Former names
Beta Bionics, Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,285,734
in 20 filings, $2.5M under 10b5-1 plans

Net −$3,285,734. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-01-31 Mensinger Mike Chief Product Officer Conversion +15,107 15,107
2025-01-31 Mensinger Mike Chief Product Officer Option exercise +10,575 $0.02 $212 25,682
2025-01-31 Mensinger Mike Chief Product Officer Sale −13 $17.00 $221 25,669
2025-01-31 Mensinger Mike Chief Product Officer Purchase +33,350 $17.00 $567K 59,019
2025-01-31 Mensinger Mike Chief Product Officer Conversion · Series D Preferred Stock −15,107 0
2025-01-31 Mensinger Mike Chief Product Officer Conversion · Class B Common Stock Warrant (right to buy) +10,575 10,575
2025-01-31 Mensinger Mike Chief Product Officer Option exercise · Class B Common Stock Warrant (right to buy) −10,575 0
2025-01-31 Mensinger Mike Chief Product Officer Grant or award · Employee Stock Option (right to buy) +236,553 236,553
2025-01-31 Mensinger Mike Chief Product Officer Grant or award · Employee Stock Option (right to buy) +110,278 110,278
2025-01-31 Jones Christy Director Grant or award · Director Stock Option (right to buy) +9,137 9,137
2025-01-31 Jones Christy Director Grant or award · Director Stock Option (right to buy) +9,137 9,137
2025-01-31 Jones Christy Director Grant or award · Director Stock Option (right to buy) +48,730 48,730
2025-01-31 Hopman Mark Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +83,242 83,242
2025-01-31 Hopman Mark Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +37,229 37,229
2025-01-31 Hopman Mark Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +17,765 17,765
2025-01-31 Hopman Mark Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +39,424 39,424
2025-01-31 Hopman Mark Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +47,775 47,775
2025-01-31 Feider Stephen Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +166,542 166,542
2025-01-31 Feider Stephen Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +109,695 109,695
2025-01-31 Feider Stephen Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +186,203 186,203

Page 10 of 11 · 210 trades